Journal
NEUROPHARMACOLOGY
Volume 81, Issue -, Pages 311-317Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2014.02.010
Keywords
Alzheimer's disease; 3xTg-AD; APP/PS1; Blood-brain barrier integrity; In situ brain perfusion; Brain vascular volume
Categories
Funding
- Paris Sud University (France)
- Paris Descartes University (France)
- Canadian Institutes of Health Research [MOP 102532]
- Fonds de la recherche en sante du Quebec (Canada)
- Laval University (Quebec, Qc, Canada)
Ask authors/readers for more resources
We evaluated the integrity and function of the blood brain barrier in 3xTg-AD mice aged 3-18 months and in APP/PS1 mice aged 8-months to determine the impacts of changes in amyloid and tau proteins on the brain vascular changes. The vascular volume (V-vasc) was sub-normal in 3xTg-AD mice aged from 6 to 18 months, but not in the APP/PSI mice. The uptakes of [H-3]-diazepam by the brains of 3xTg-AD, APP/PSI and their age-matched control mice were similar at all the times studied, suggesting that the simple diffusion of small solutes is unchanged in transgenic animals. The uptake of D-glucose by the brains of 18month old 3xTg-AD mice, but not by those of 8-month old APP/PS1 mice, was reduced compared to their age-matched controls. Accordingly, the amount of Glut-1 protein was 1.4 times lower in the brain capillaries of 18 month-old 3xTg-AD mice than in those of age-matched control mice. We conclude that the brain vascular volume is reduced early in 3xTg-AD mice, 6 months before the appearance of pathological lesions, and that this reduction persists until they are at least 18 months old. The absence of alterations in the BBB of APP/PSI mice suggests that hyperphosphorylated tau proteins contribute to the vascular changes that occur in AD. (C) 2014 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available